Is Compounding A Practical Opportunity For Your Pharmacy? | Pharmacy CrossRoads

Is Compounding A Practical Opportunity For Yo...

Up next

Leadership Under Pressure in Community Pharmacy | Executive Dose

In this episode of Executive Dose, Marc Essensa, CEO at IPC, joins the conversation to discuss what leadership looks like inside community pharmacy during one of the most pressured moments in the profession. The episode explores how vision, strategy, ethics, and creative thinking ...  Show more

Building a Diverse Content Strategy That Works| Marketing Vitals

A strong marketing strategy depends on the variety and relevance of your content. In this episode, we dive into what a diverse content strategy is, why it matters, and how it can elevate your marketing efforts. We’ll highlight the key benefits of producing varied content, common ...  Show more

Recommended Episodes

The Future of Personalized Medicine | Shaun Noorian
The Dr. Gabrielle Lyon Show

In this episode of the Dr. Gabrielle Lyon Show, we dive deep into the world of compounding pharmacies and the transformative power of anabolic steroids with special guest Shaun Noorian, founder of Empower Pharmacy, one of the largest compounding pharmacies in the U.S.Join us as S ...  Show more

531: Growing a Medical Practice with Dr. Rao
The How of Business - How to start, run, grow and exit a small business.

How to grow a Medical Practice with Dr. Ramesh Rao.

<span style= "mso-bookmark: _Hlk160446384;">Show Notes Page:</span> <span style="mso-bookmark: _Hlk160446384; ...

  Show more

What Every Medical Student Should Know About Integrative Medicine
Spoonful of Sugar

Have you heard of the specialty of integrative medicine? What is it, and how does an integrative medicine physician care for their patients? In this episode, Ria interviews Dr. Chiti Parikh, who is board certified in integrative medicine and is the executive director of the Integ ...  Show more

FDA ends GLP-1 compounding for semaglutide, tirzepatide
Healthcare Strategies

FDA’s removal of GLP-1 drugs from the shortage list ends supplemental compounding, shifting patient access back to branded semaglutide and tirzepatide. Featuring: Sara Heath, executive editor, Xtelligent Healthcare Alivia Kaylor, senior editor of Pharma Life Sciences, Xtelligent ...  Show more